Survey of United States child and adolescent Psychiatrists' cardiac screening practices prior to starting patients on stimulants

Journal of Child and Adolescent Psychopharmacology

Volumn 22, Issue 5, 2012, Pages 375-384

  Leslie, Laurel K ^a,b   Rodday, Angie Mae ^a   Saunders, Tully S ^a   Cohen, Joshua T ^a   Wong, John B ^b   Sheldrick, R Christopher ^a   Parsons, Susan K ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CARDIAC SCREENING; CARDIOVASCULAR RISK; CHILD; COMMUNITY MENTAL HEALTH CENTER; CROSS-SECTIONAL STUDY; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICOLEGAL ASPECT; PATIENT EDUCATION; PATIENT REFERRAL; PHYSICAL EXAMINATION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIVATE HEALTH INSURANCE; PRIVATE PRACTICE; PSYCHIATRIST; SCHOOL CHILD; SCREENING; SUDDEN DEATH; UNITED STATES;

ADOLESCENT; ADOLESCENT PSYCHIATRY; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ATTITUDE OF HEALTH PERSONNEL; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HEALTH CARE SURVEYS; HEART DISEASES; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRY; RISK ASSESSMENT; UNITED STATES;

EID: 84867792265     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0141     Document Type: Article

References (33)

1. American Academy of Child and Adolescent Psychiatry Committee on Health Care Access and Economics Task Force on Mental Health: Improving mental health services in primary care: Reducing administrative and financial barriers to access and collaboration. Pediatrics 123:1248-1251, 2009.
2. Allison PD: Logistic Regression Using SAS: Theory and Application. Cary, NC: SAS Institute, Inc., 1999.
3. American Academy of Pediatrics/American Heart Association: American Academy of Pediatrics/American Heart Association Clarification of Statement on Cardiovascular Evaluation and Monitoring of Children and Adolescents With Heart Disease Receiving Medications for ADHD. 2008. Available at http://www2.aap.org/ pressroom/aap-ahastatement.htm. Accessed June 15, 2011.
4. Berry SH, Kanouse DE: Physician response to a mailed survey: An experiment in timing of payment. Public Opin Q 51:102-114, 1987.
5. Center for Workforce Studies: 2008 Physician Specialty Data. Washington, DC: Association of American Medical Colleges, 2008.
6. Chenven M: Community systems of care for children's mental health. Child Adolescent Psychiatr Clin N Am 19:163-174, 2010.
7. Collins D: Pretesting survey instruments: An overview of cognitive methods. Qual Life Res 12:229-238, 2003. (Pubitemid 36549531)
8. Committee on Collaboration with Medical Professionals: A Guide to Building Collaborative Mental Health Care Partnerships in Pediatric Primary Care. American Academy of Child and Adolescent Psychiatry, 2010.
9. Committee on Psychosocial Aspects of Child and Family Health and Task Force on Mental Health: The future of pediatrics: Mental health competencies for pediatric primary care. Pediatrics 124:410-421, 2009.
10. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA: ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365:1896-1904, 2011.
11. Cummings SM, Savitz LA, Konrad TR: Reported response rates to mailed physician questionnaires. Health Serve Res 35:1347-1355, 2001. (Pubitemid 32163983)
12. Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T: Sudden death and use of stimulant medications in youths. Am J Psychiatry 166:992-1001, 2009.
13. Institute of Medicine (US): Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press, 2001.
14. Kim WJ: Child and adolescent psychiatry workforce: A critical shortage and national challenge. Acad Psychiatry 27:277-282, 2003. (Pubitemid 38180510)
15. Leslie LK, Cohen JT, Newburger JW, Alexander ME, Wong JW, Sherwin ED, Rodday AM, Parsons SK, Triedman JT: Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation 125:2621-2629, 2012.
16. Leslie LK, Rodday A, Saunders TS, Cohen JT, Wong JB, Parsons SK: Cardiac screening prior to stimulant treatment for ADHD: A survey of US-based pediatricians. Pediatrics 129:222-230, 2012b.
17. Parsons SK, Saiki-Craighill S, Mayer DK, Sullivan AM, Jeruss S, Terrin N, Tighiouart H, Nakagawa K, Iwata Y, Hara J, Grier HE, Block S: Telling children and adolescents about their cancer diagnosis: Cross-cultural comparisons between pediatric oncologists in the US and Japan. Psychooncology 16:60-68, 2007. (Pubitemid 46189078)
18. Perrin JM, Friedman RA, Knilans TK, the Black Box Working Group, the Section on Cardiology and Cardiac Surgery: Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics 122:451-453, 2008.
19. Pliszka S: Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:894-921, 2007.
20. Ranz JM, Vergare MJ, Wilk JE, Ackerman SH, Lippincott RC, Menninger WW, Sharfstein SS, Sullivan A: The tipping point from private practice to publicly funded settings for early-and mid-career psychiatrists. Psychiatr Serv 57:1640-1643, 2006. (Pubitemid 44807045)
21. Rosack J: FDA panel wants warnings on ADHD medications. Psychiatr News 41:1-36, 2006.
22. Ross WJ, Chan E, Harris SK, Goldman SJ, Rappaport LA: Pediatrician-psychiatrist collaboration to care for children with attention deficit hyperactivity disorder, depression, and anxiety. Clin Pediatr 50:37-43, 2011.
23. Sarvet BD, Wegner L: Developing effective child psychiatry collaboration with primary care: Leadership and management strategies. Child Adolescent Psychiatr Clin N Am 19:139-148, 2010.
24. Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S: Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 127:1102-1110, 2011.
25. Sofaer S: Qualitative methods: What are they and why use them? Health Serv Res 34:1101-1118, 1999.
26. Stubbe DE, Thomas W: A survey of early-career child and adolescent psychiatrists: Professional activities and perceptions. J Am Acad Child Adolesc Psychiatry 41:123-130, 2002. (Pubitemid 38344099)
27. Thomas C, Holzer CE III: The continuing shortage of child and adolescent psychiatrists. J Am Acad Child Adolesc Psychiatry 45:1023-1031, 2006. (Pubitemid 44348741)
28. U.S. Department of Health & Human Services: HITECH Programs. The Office of the National Coordinator for Health Information Technologies 2011. Available at http://healthit.hhs.gov/portal/server .pt/community/healthit-hhs- gov-hitech-programs/1487. Accessed August 5, 2011.
29. U.S. Food and Drug Administration. Public Health Advisory for Adderall and Adderall XR.February 9, 2005. Available at: Http:// www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformation forPatientsandProviders/ DrugSafetyInformationforHeathcare Professionals/PublicHealthAdvisories/ ucm051672.htm. Accessed June 15, 2011
30. U.S. Food and Drug Administration. Statement on Adderall, 2005. Available at http://www.fda.gov/NewsEvents/Newsroom/Press Announcements/2005/ucm108411. htm. Accessed June 15, 2011.
31. Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, Webb CL: Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation 117:2407-2423, 2008. (Pubitemid 351653546)
32. Zachik AA, Naylor MW, Klaehn RL: Child and adolescent psychiatry leadership in public mental health, child welfare, and developmental disabilities agencies. Child Adolescent Psychiatr Clin N Am 19:47-61, 2010.
33. Zuckerman KE, Nelson K, Bryant TK, Hobrecker K, Perrin JM, Donelan K: Specialty referral communication and completion in the community health center setting. Acad Pediatr 11:288-296, 2011.